Pre-market: Higher opening seen; RIL, United Bank of India in focus

Glenmark Pharma up on plans to out-license molecule for pain management

The molecule, GRC 17536, is expected to have a market potential worth $ 1 billion.

Pre-market: Higher opening seen; RIL, United Bank of India in focus

Glenmark Pharma up on plans to out-license molecule for pain management

The molecule, GRC 17536, is expected to have a market potential worth $ 1 billion.

SGX Nifty

sgxnifty.org@imediaone.com

You may also like...

Rules of Discussion on Pre-market: Higher opening seen; RIL, United Bank of India in focus

1. This forum is for discussion of financial markets. Please respect others view even if they are contrary to you.
2. Member's comments should lead to value addition in forum discussion.
3. If anyone is found making repetitive Explicit/Abusive/Racial comments, his account shall be banned and old posts will be deleted.
4. Providing Advice/Recommendations/Tips is fine but it should be free. Members cannot ask to be paid for it. Paid Advice is stricly prohibited
5. Spam links are not allowed. Too much promotion or using Contact info in ID will lead to account ban.
IMP : Memebrs are requeuested to flag any violations to keep Forum Clean